-
Diagnostics World News | After nearly three years of dealing with COVID-19, the last thing anyone wants to hear is news of another looming global health crisis. Unlike COVID-19, this one has been lurking for some time. Scientists, doctors, nurses, pharmacists, and patients have a unique ability and responsibility to address the problem before it gets out of control. The looming crisis is antimicrobial resistance.
Nov 11, 2022
-
Diagnostics World News | A Yale research team discovered that newborn metabolic screening data could identify human ancestry and help practitioners diagnose genetic diseases.
Nov 10, 2022
-
Diagnostics World News | A recent study revealed that people ages 65 and older who caught COVID-19 were more likely to develop Alzheimer’s disease shortly thereafter. The findings showed that the risk of developing Alzheimer’s almost doubled in this population of older adults over the one-year period following a COVID-19 diagnosis.
Nov 8, 2022
-
Diagnostics World News | Diagnosing sepsis is a longstanding challenge in medicine because the clinical signs and symptoms are nonspecific and, in the absence of a gold standard for identifying patients with the disease, the focus has remained largely on identifying the culprit pathogen. But an assay developed by University of California, San Francisco researchers that deploys metagenomic next-generation sequencing of both pathogens and host immune response could be a real gamechanger.
Nov 3, 2022
-
Diagnostics World News | Robust levels of large extracellular vesicles (LEVs) were found “hiding in plain sight” in the blood of early-stage breast cancer patients in a recent study led by a team of scientists at the University of Southern California. The LEVs are roughly the size of a cell and found while using a high-definition liquid biopsy platform to stratify normal donors from those with early- or late-stage breast cancer.
Nov 1, 2022
-
Diagnostics World News | Clinical whole exome sequencing services identify possible disease-causing genetic changes; a composite biomarker system uses multiple clinically relevant patient features to reflect the heterogeneity of graft failure; a regulatory science tool improves the review processes for stroke rehabilitation devices; and more.
Oct 27, 2022
-
Diagnostics World News | Funding for biomarker analysis for patients with nonalcoholic fatty liver disease, improving early diagnosis and survival rates of patients with nasopharyngeal cancer, genome sequencing analysis of the Epstein-Barr virus, and more.
Oct 26, 2022
-
Diagnostics World News | A medical technology startup based in Auckland, New Zealand, expects its pioneering Gastric Alimetry wearable device for diagnosing gut disorders will one day do for gastroenterology what ECG testing for heart abnormalities has done for cardiology.
Oct 20, 2022
-
Diagnostics World News | A University of Birmingham research team is developing a rapid diagnostic test for gum disease, a tool they foresee assisting in the early detection of heart and lung disease, type 2 diabetes, and rheumatoid arthritis.
Oct 19, 2022
-
Diagnostics World News | A team of French and Canadian investigators found that smartwatches often misdiagnose atrial fibrillation patients with at least one preexisting heart condition, insinuating that smartwatches may not be as smart as we think.
Oct 18, 2022
-
Diagnostics World News | A team of Swedish researchers from Uppsala and Lund Universities created the first large-scale microbial atlas, linking gut microbiota to specific metabolites and their potential health impact on humans.
Oct 13, 2022
-
Diagnostics World News | Screenings for heart-related conditions have woven their way into routine health care, like the blood pressure checks that take place at many medical appointments. So why isn’t there a quick and easy method to regularly evaluate brain health? It’s a question some are looking to address with the help of artificial intelligence (AI) and machine learning-based approaches.
Oct 11, 2022
-
Diagnostics World News | Research institutes representing five western European countries—Finland, Germany, Norway, Spain, and Sweden—will become the first to join the Federated European Genome-phenome Archive, an international distributed data network designed to share highly-sensitive human ’omics data internationally.
Oct 6, 2022
-
Diagnostics World News | Experiences at the Mayo Clinic integrating metagenomic next-generation sequencing into clinical practice was one of the featured presentations at the recent Next Generation Dx Summit in Washington, D.C. Keynote speaker Robin M. Patel, M.D., focused primarily on the use of the targeted-based approach where the 16S ribosomal RNA (rRNA) gene is being analyzed.
Oct 5, 2022
-
Diagnostics World News | A team of researchers from Stanford University and the Georgia Institute of Technology designed a malleable, battery-operated wearable sensor that continuously monitors subcutaneous tumor progression, regression, and treatment efficacy.
Oct 4, 2022
-
Diagnostics World News | An RNA-based diagnostic workflow for detecting mRNA expression of standard breast cancer biomarkers; an automated TB test for immunocompromised patients; a companion diagnostic for detecting genomic alterations; and more.
Sep 29, 2022
-
Diagnostics World News | Funding for voice-based diagnostics, machine learning algorithms that detect and stratify pulmonary hypertension, immunohistochemistry cancer diagnostics, and more.
Sep 28, 2022
-
Diagnostics World News | Emerging approaches to the early detection of cancer were highlighted during the recent Next Generation Dx Summit held in Washington, D.C. Representatives from diagnostics companies Oxomics, Elypta, Micronoma, and Rivela Diagnostics took turns making their case for a new generation of technologies hunting for elusive molecular signatures of a highly heterogenous group of diseases.
Sep 22, 2022
-
Diagnostics World News | Ongoing collaboration between the fields of immunotherapy and liquid biopsy has opened vast opportunities to improve the care of cancer patients, including the prevention of full-blown disease or relapse. It was also the focus of several talks at the recent Next Generation Dx Summit, including a keynote on the long-hoped-for promise of liquid biopsy approaches for diagnosing and treating solid tumors.
Sep 21, 2022
-
Diagnostics World News | The National Institutes of Health (NIH) seeks to award up to $300 million to diagnostic test manufacturers for developing improved next-generation COVID-19 tests. The two main objectives will be to increase testing performance and accessibility.
Sep 20, 2022